Related Experiment Video
Updated: Jun 13, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Working together: Farnesyl transferase inhibitors and statins block protein prenylation
Jonathan W Wojtkowiak1, Richard A Gibbs, Raymond R Mattingly
1Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan.
Abstract:
Farnesyl transferase inhibitors (FTIs) have so far proved to have limited value as single agents in clinical trials. This PharmSight will focus on the use of a novel group of FTIs that are most effective in vitro when used in combination with the "statin" class of anti-hypercholesterolemic agents, which also block protein prenylation. We recently showed that these novel FTIs in combination with lovastatin reduce Ras prenylation and induce an apoptotic response in malignant peripheral nerve sheath cells. The combination of statins with these new FTIs may produce profound synergistic cytostatic and cytotoxic effects against a variety of tumors and other proliferative disorders. Since statins are well tolerated in the clinic, we suggest that this combination approach should be tested in in vivo models.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Regulation of Nuclear Protein Sorting
Inhibitors of Bacterial Protein Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
